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The last paragraph of the Discussion section describing recent studies on retinoblastoma in mice mistakenly does not make reference to the
work of Chen et al. (2004). The text should read as follows:
‘‘Recent studies on retinoblastoma in mice may provide an example of this scenario. Inactivation of Rb in the murine retina resulted in pro-
liferation of differentiating retinal precursors, which was enhanced by additional loss of p107 (Chen et al., 2004). While the majority of the
retinal cells (rods, cones, and ganglion and bipolar cells) subsequently underwent apoptosis, amacrine precursors arrested (Chen et al.,
2004). The latter compartment gave rise to retinoblastomas in Rbp130- and Rbp107-deficient retinas, suggesting that alleviation of cell cycle
arrest rather than suppression of apoptosis was required for oncogenic transformation of pocket protein-deficient cells (Robanus-Maandag
et al., 1998; Chen et al., 2004; Dannenberg et al., 2004; MacPherson et al., 2004; Zhang et al., 2004).’’
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